Cargando…
Modelling of the cancer cell cycle as a tool for rational drug development: A systems pharmacology approach to cyclotherapy
The dynamic of cancer is intimately linked to a dysregulation of the cell cycle and signalling pathways. It has been argued that selectivity of treatments could exploit loss of checkpoint function in cancer cells, a concept termed “cyclotherapy”. Quantitative approaches that describe these dysregula...
Autores principales: | Jackson, Robert C., Di Veroli, Giovanni Y., Koh, Siang-Boon, Goldlust, Ian, Richards, Frances M., Jodrell, Duncan I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435348/ https://www.ncbi.nlm.nih.gov/pubmed/28467408 http://dx.doi.org/10.1371/journal.pcbi.1005529 |
Ejemplares similares
-
An automated fitting procedure and software for dose-response curves with multiphasic features
por: Veroli, Giovanni Y. Di, et al.
Publicado: (2015) -
Cyclotherapy: opening a therapeutic window in cancer treatment
por: van Leeuwen, Ingeborg M.M.
Publicado: (2012) -
Combenefit: an interactive platform for the analysis and visualization of drug combinations
por: Di Veroli, Giovanni Y., et al.
Publicado: (2016) -
Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapy
por: Rao, Bhavya, et al.
Publicado: (2010) -
p53-Based cyclotherapy: exploiting the ‘guardian of the genome' to protect normal cells from cytotoxic therapy
por: Rao, B, et al.
Publicado: (2013)